ScholarLens Back to search
2004•Ningxia Medical JournalRequires access

The application of different on centration of mitomycin C in external dacryocystorhinostomy

Luo Yan-sha

Open publisher page 0 citations

Abstract

Objective To assess the efficacy and safe of intraoperative mitomycin C(MMC)in external dacryocystorhinostomy(EXT-DCR).Methods Fifty-one cases with chronic dacryocystitis were randomized into two groups.There were MMC group 26 cases and the control group 25 cases.In the control group,a standard EXT-DCR procedure was performed. In the MMC groups, a piece of cotton soaked with 0.5g/L MMC was applied to the nasal mucosa and the mucosa of the lacrimal sac in the osteotomy site for 5 minutes.A mean follow-up interval of 27.8± 3.9 months.Results The success rate was 25 (96.2%) of 26 cases in MMC group,and 21 (84%) of 25 cases in the control group.Between the patients treated with MMC and the control group was statistically significant(P0.05).Conclusion Intraoperative MMC in EXT-DCR is a safe and effective adjuvant that helps achieve favorable long-term.

About this research paper

What this paper is about

Objective To assess the efficacy and safe of intraoperative mitomycin C(MMC)in external dacryocystorhinostomy(EXT-DCR).Methods Fifty-one cases with chronic dacryocystitis were randomized into two groups.There were MMC group 26 cases and the control group 25 cases.In the control group,a standard EXT-DCR procedure was performed. In the MMC groups, a piece of cotton soaked with 0.5g/L MMC was applied to the nasal mucosa and the mucosa of the lacrimal sac in the osteotomy site for 5 minutes.A mean follow-up interval of 27.8± 3.9 months.Results The success rate was 25 (96.2%) of 26 cases in MMC group,and 21 (84%) of 25 cases in the control group.Between the patients treated with MMC and the control group was statistically significant(P0.05).Conclusion Intraoperative MMC in EXT-DCR is a safe and effective adjuvant that helps achieve favorable long-term.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To assess the efficacy and safe of intraoperative mitomycin C(MMC)in external dacryocystorhinostomy(EXT-DCR).Methods Fifty-one cases with chronic dacryocystitis were randomized into two groups.There were MMC group 26 cases and the control group 25 cases.In the control group,a standard EXT-DCR procedure was performed. In the MMC groups, a piece of cotton soaked with 0.5g/L MMC was applied to the nasal mucosa and the mucosa of the lacrimal sac in the osteotomy site for 5 minutes.A mean follow-up interval of 27.8± 3.9 months.Results The success rate was 25 (96.2%) of 26 cases in MMC group,and 21 (84%) of 25 cases in the control group.Between the patients treated with MMC and the control group was statistically significant(P0.05).Conclusion Intraoperative MMC in EXT-DCR is a safe and effective adjuvant that helps achieve favorable long-term.

Key concepts: Medicine, Dacryocystorhinostomy, Mitomycin C, Chronic dacryocystitis, Surgery, Dacryocystitis, Mucous membrane of nose, Lacrimal sac

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The application of different on centration of mitomycin C in external dacryocystorhinostomy — Research Paper | ScholarLens